1. Home
  2. ATAI vs VRE Comparison

ATAI vs VRE Comparison

Compare ATAI & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • VRE
  • Stock Information
  • Founded
  • ATAI 2018
  • VRE 1949
  • Country
  • ATAI Netherlands
  • VRE United States
  • Employees
  • ATAI N/A
  • VRE N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • VRE Real Estate Investment Trusts
  • Sector
  • ATAI Health Care
  • VRE Real Estate
  • Exchange
  • ATAI Nasdaq
  • VRE Nasdaq
  • Market Cap
  • ATAI 1.6B
  • VRE 1.4B
  • IPO Year
  • ATAI 2021
  • VRE 1994
  • Fundamental
  • Price
  • ATAI $3.66
  • VRE $15.07
  • Analyst Decision
  • ATAI Strong Buy
  • VRE Buy
  • Analyst Count
  • ATAI 5
  • VRE 4
  • Target Price
  • ATAI $14.00
  • VRE $18.25
  • AVG Volume (30 Days)
  • ATAI 5.2M
  • VRE 597.9K
  • Earning Date
  • ATAI 11-12-2025
  • VRE 10-22-2025
  • Dividend Yield
  • ATAI N/A
  • VRE 2.12%
  • EPS Growth
  • ATAI N/A
  • VRE N/A
  • EPS
  • ATAI N/A
  • VRE 0.68
  • Revenue
  • ATAI $3,018,000.00
  • VRE $291,348,000.00
  • Revenue This Year
  • ATAI $736.04
  • VRE $6.48
  • Revenue Next Year
  • ATAI N/A
  • VRE N/A
  • P/E Ratio
  • ATAI N/A
  • VRE $23.99
  • Revenue Growth
  • ATAI 811.78
  • VRE 6.39
  • 52 Week Low
  • ATAI $1.15
  • VRE $13.69
  • 52 Week High
  • ATAI $6.75
  • VRE $18.61
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 26.67
  • VRE 52.10
  • Support Level
  • ATAI $3.72
  • VRE $14.70
  • Resistance Level
  • ATAI $4.65
  • VRE $15.22
  • Average True Range (ATR)
  • ATAI 0.35
  • VRE 0.31
  • MACD
  • ATAI -0.13
  • VRE 0.03
  • Stochastic Oscillator
  • ATAI 0.80
  • VRE 65.49

About ATAI ATAI Life Sciences N.V.

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

Share on Social Networks: